Group One Trading
GALT icon

Group One Trading’s Galectin Therapeutics GALT Stock Holding History

Group One Trading’s Portfolio GALT Stock Details GALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.8K Buy
+13,753
New +$35.6K ﹤0.01% 5202
2025
Q4 		– Sell
-99,110
Closed -$522K – 8480
2025
Q3 		$420K Buy
99,110
+32,914
+50% +$124K ﹤0.01% 3871
2025
Q2 		$140K Buy
+66,196
New +$99K ﹤0.01% 4677
2024
Q2 		– Sell
-542
Closed -$1.65K – 6985
2024
Q1 		$1.29K Buy
+542
New +$1.02K ﹤0.01% 6578
2021
Q2 		– Sell
-2,976
Closed -$10.6K – 8281
2021
Q1 		$6K Sell
2,976
-5,000
-63% -$11.2K ﹤0.01% 7199
2020
Q4 		$18K Buy
+7,976
New +$20.9K ﹤0.01% 5569
2020
Q3 		– Sell
-4,824
Closed -$13.5K – 6236
2020
Q2 		$15K Buy
4,824
+65
+1% +$164 ﹤0.01% 4949
2020
Q1 		$9K Buy
+4,759
New +$11.6K ﹤0.01% 4595
2019
Q4 		– Sell
-794
Closed -$2.76K – 5255
2019
Q3 		$3K Sell
794
-14,768
-95% -$53.4K ﹤0.01% 4855
2019
Q2 		$65K Buy
+15,562
New +$67.4K ﹤0.01% 3628
2019
Q1 		– Sell
-4,965
Closed -$23.8K – 4994
2018
Q4 		$17K Sell
4,965
-42,000
-89% -$201K ﹤0.01% 4082
2018
Q3 		$282K Sell
46,965
-61,526
-57% -$339K ﹤0.01% 2756
2018
Q2 		$690K Buy
108,491
+103,339
+2,006% +$503K 0.01% 2038
2018
Q1 		$24K Buy
+5,152
New +$24K ﹤0.01% 4011
2017
Q4 		– Sell
-23,052
Closed -$58.3K – 4958
2017
Q3 		$49K Buy
+23,052
New +$45.7K ﹤0.01% 3648

Other funds holding GALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Group One Trading's GALT Position: Q2 2026 in Review

Group One Trading opened a new position in Galectin Therapeutics (GALT) in Q2 2026: 13,753 shares worth $63.8K. The stake represents ﹤0.01% of the portfolio and ranks #5202 among its holdings. This is a return to the name: Group One Trading previously reported a position in GALT as recently as Q3 2025.

Group One Trading first reported a position in GALT in Q3 2017 and has held it in 15 quarters since. The position peaked at $690K in Q2 2018. 98 funds tracked by Wall St. Rank hold GALT as of Q2 2026.

  • Group One Trading held 13,753 shares of Galectin Therapeutics worth $63.8K as of Q2 2026.
  • Galectin Therapeutics was a new Group One Trading position in Q2 2026.
  • Galectin Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #5202 holding.
  • Group One Trading first reported a position in Galectin Therapeutics in Q3 2017 and has held it in 15 quarters since.
  • Group One Trading's Galectin Therapeutics position peaked at $690K in Q2 2018.
  • 98 funds tracked by Wall St. Rank held Galectin Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.